Literature DB >> 1212563

Postnatal development of dopamine deamination in the striatum of the rat.

A J Davis, M Holzbauer, D F Sharman.   

Abstract

In the striata of litter-mate rats the development of the monoamine oxidase (MAO) activity towards dopamine in vitro followed a similar time course with age as the tissue concentrations of homovanillic acid and dihydroxphenylacetic acid, the two acid metabolites of dopamine formed by the action of MAO.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1212563      PMCID： PMC1666736          DOI： 10.1111/j.1476-5381.1975.tb07433.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  4 in total

1.  Proceedings: Substrate and strain-dependent differences in the development of monoamine oxidase in the rat brain.

Authors:  D Blatchford; M Holzbauer; M B Youdim
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.

Authors:  D S Robinson; W Lovenberg; H Keiser; A Sjoerdsma
Journal:  Biochem Pharmacol       Date:  1968-01       Impact factor: 5.858

3.  Spontaneous and drug-induced changes of cerebral dopamine turnover during postnatal development of rats.

Authors:  H H Keller; G Bartholini; A Pletscher
Journal:  Brain Res       Date:  1973-12-21       Impact factor: 3.252

4.  The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse.

Authors:  G F Murphy; D Robinson; D F Sharman
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739
  4 in total
  3 in total

1.  Ontogenesis of enzyme systems deaminating different monoamines.

Authors:  D Blatchford; M Holzbauer
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

Review 2.  Physiological and pathological changes in tissue monoamine oxidase activity.

Authors:  M B Youdim; M Holzbauer
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

3.  Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia.

Authors:  Alexandra I Zugno; Ricardo Filipe Julião; Josiane Budni; Ana Maria Volpato; Daiane B Fraga; Felipe D Pacheco; Pedro F Deroza; Renata D Luca; Mariana B de Oliveira; Alexandra S Heylmann; João Quevedo
Journal:  Metab Brain Dis       Date:  2013-06-19       Impact factor: 3.584
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.